APO Research
Talk to an analyst

APO RESEARCH · REPORT

DNA Subcloning Services

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global DNA Subcloning Services Market Analysis and Forecast 2026-2032

15 April 2026245 pages

Choose your research edition.

Industry ResearchDNA Subcloning Services Industry Research Report 2026134 pages · $2,950 USDIndustry Growth & TrendsGlobal DNA Subcloning Services Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal DNA Subcloning Services Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal DNA Subcloning Services Market Outlook and Growth Opportunities 2026$4,250 USDMarket Analysis & ForecastGlobal DNA Subcloning Services Market Analysis and Forecast 2026-2032245 pages · $4,950 USD

Market perspective

The global DNA Subcloning Services market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for DNA Subcloning Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for DNA Subcloning Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for DNA Subcloning Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for DNA Subcloning Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of DNA Subcloning Services include Sydlabs, GenScript, Thermo Fisher Scientific, OriGene, Eton Bioscience, Synbio Technologies, Eurofins Genomics, Tsingke Biotech and MCLAB, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for DNA Subcloning Services, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of DNA Subcloning Services, also provides the revenue of main regions and countries. Of the upcoming market potential for DNA Subcloning Services, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the DNA Subcloning Services revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global DNA Subcloning Services market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for DNA Subcloning Services revenue, projected growth trends, production technology, application and end-user industry.

DNA Subcloning Services Segment by Company

Sydlabs

GenScript

Thermo Fisher Scientific

OriGene

Eton Bioscience

Synbio Technologies

Eurofins Genomics

Tsingke Biotech

MCLAB

Innoprot

Applied Biological Materials Inc. (abm)

BaseGene

Gencefebio

FIVEphoton Biochemicals

1st BASE

DNA Subcloning Services Segment by Type

Restriction Enzyme-based Subcloning

PCR-based Subcloning

Other

DNA Subcloning Services Segment by Application

Biotechnology

Pharmaceuticals

Basic Research

Others

DNA Subcloning Services Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global DNA Subcloning Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of DNA Subcloning Services and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of DNA Subcloning Services.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of DNA Subcloning Services in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of DNA Subcloning Services company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, DNA Subcloning Services revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global DNA Subcloning Services Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Restriction Enzyme-based Subcloning Major Player Table 3. PCR-based Subcloning Major Player Table 4. Other Major Player Table 5. Global DNA Subcloning Services Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Biotechnology Major Player Table 7. Pharmaceuticals Major Player Table 8. Basic Research Major Player Table 9. Others Major Player Table 10. DNA Subcloning Services Industry Trends Table 11. DNA Subcloning Services Industry Drivers Table 12. DNA Subcloning Services Industry Opportunities and Challenges Table 13. DNA Subcloning Services Industry Restraints Table 14. Global DNA Subcloning Services Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 15. Global DNA Subcloning Services Market Size by Region (2021-2026) & (US$ Million) Table 16. Global DNA Subcloning Services Market Share by Region (2021-2026) Table 17. Global DNA Subcloning Services Market Size by Region (2027-2032) & (US$ Million) Table 18. Global DNA Subcloning Services Market Share by Region (2027-2032) Table 19. Global DNA Subcloning Services Revenue by Players (US$ Million) & (2021-2026) Table 20. Global DNA Subcloning Services Revenue Market Share by Players (2021-2026) Table 21. Global DNA Subcloning Services Key Players Ranking, 2024 VS 2025 VS 2026 Table 22. Global DNA Subcloning Services Key Players Headquarters & Area Served Table 23. Global DNA Subcloning Services Players, Product Type & Application Table 24. Global DNA Subcloning Services Players Establishment Date Table 25. Global Players Market Concentration Ratio (CR5 and HHI) Table 26. Global DNA Subcloning Services by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 27. Global DNA Subcloning Services Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global DNA Subcloning Services Revenue by Type (2021-2026) & (US$ Million) Table 29. Global DNA Subcloning Services Revenue by Type (2027-2032) & (US$ Million) Table 30. Global DNA Subcloning Services Revenue Market Share by Type (2021-2026) Table 31. Global DNA Subcloning Services Revenue Market Share by Type (2027-2032) Table 32. Global DNA Subcloning Services Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global DNA Subcloning Services Revenue by Application (2021-2026) & (US$ Million) Table 34. Global DNA Subcloning Services Revenue by Application (2027-2032) & (US$ Million) Table 35. Global DNA Subcloning Services Revenue Market Share by Application (2021-2026) Table 36. Global DNA Subcloning Services Revenue Market Share by Application (2027-2032) Table 37. Sydlabs Company Information Table 38. Sydlabs Business Overview Table 39. Sydlabs DNA Subcloning Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. Sydlabs DNA Subcloning Services Product Portfolio Table 41. Sydlabs Recent Development Table 42. GenScript Company Information Table 43. GenScript Business Overview Table 44. GenScript DNA Subcloning Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. GenScript DNA Subcloning Services Product Portfolio Table 46. GenScript Recent Development Table 47. Thermo Fisher Scientific Company Information Table 48. Thermo Fisher Scientific Business Overview Table 49. Thermo Fisher Scientific DNA Subcloning Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. Thermo Fisher Scientific DNA Subcloning Services Product Portfolio Table 51. Thermo Fisher Scientific Recent Development Table 52. OriGene Company Information Table 53. OriGene Business Overview Table 54. OriGene DNA Subcloning Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. OriGene DNA Subcloning Services Product Portfolio Table 56. OriGene Recent Development Table 57. Eton Bioscience Company Information Table 58. Eton Bioscience Business Overview Table 59. Eton Bioscience DNA Subcloning Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. Eton Bioscience DNA Subcloning Services Product Portfolio Table 61. Eton Bioscience Recent Development Table 62. Synbio Technologies Company Information Table 63. Synbio Technologies Business Overview Table 64. Synbio Technologies DNA Subcloning Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. Synbio Technologies DNA Subcloning Services Product Portfolio Table 66. Synbio Technologies Recent Development Table 67. Eurofins Genomics Company Information Table 68. Eurofins Genomics Business Overview Table 69. Eurofins Genomics DNA Subcloning Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. Eurofins Genomics DNA Subcloning Services Product Portfolio Table 71. Eurofins Genomics Recent Development Table 72. Tsingke Biotech Company Information Table 73. Tsingke Biotech Business Overview Table 74. Tsingke Biotech DNA Subcloning Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. Tsingke Biotech DNA Subcloning Services Product Portfolio Table 76. Tsingke Biotech Recent Development Table 77. MCLAB Company Information Table 78. MCLAB Business Overview Table 79. MCLAB DNA Subcloning Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 80. MCLAB DNA Subcloning Services Product Portfolio Table 81. MCLAB Recent Development Table 82. Innoprot Company Information Table 83. Innoprot Business Overview Table 84. Innoprot DNA Subcloning Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 85. Innoprot DNA Subcloning Services Product Portfolio Table 86. Innoprot Recent Development Table 87. Applied Biological Materials Inc. (abm) Company Information Table 88. Applied Biological Materials Inc. (abm) Business Overview Table 89. Applied Biological Materials Inc. (abm) DNA Subcloning Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 90. Applied Biological Materials Inc. (abm) DNA Subcloning Services Product Portfolio Table 91. Applied Biological Materials Inc. (abm) Recent Development Table 92. BaseGene Company Information Table 93. BaseGene Business Overview Table 94. BaseGene DNA Subcloning Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 95. BaseGene DNA Subcloning Services Product Portfolio Table 96. BaseGene Recent Development Table 97. Gencefebio Company Information Table 98. Gencefebio Business Overview Table 99. Gencefebio DNA Subcloning Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 100. Gencefebio DNA Subcloning Services Product Portfolio Table 101. Gencefebio Recent Development Table 102. FIVEphoton Biochemicals Company Information Table 103. FIVEphoton Biochemicals Business Overview Table 104. FIVEphoton Biochemicals DNA Subcloning Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 105. FIVEphoton Biochemicals DNA Subcloning Services Product Portfolio Table 106. FIVEphoton Biochemicals Recent Development Table 107. 1st BASE Company Information Table 108. 1st BASE Business Overview Table 109. 1st BASE DNA Subcloning Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 110. 1st BASE DNA Subcloning Services Product Portfolio Table 111. 1st BASE Recent Development Table 112. North America DNA Subcloning Services Revenue by Type (2021-2026) & (US$ Million) Table 113. North America DNA Subcloning Services Revenue by Type (2027-2032) & (US$ Million) Table 114. North America DNA Subcloning Services Revenue by Application (2021-2026) & (US$ Million) Table 115. North America DNA Subcloning Services Revenue by Application (2027-2032) & (US$ Million) Table 116. North America DNA Subcloning Services Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 117. North America DNA Subcloning Services Revenue by Country (2021-2026) & (US$ Million) Table 118. North America DNA Subcloning Services Revenue by Country (US$ Million) & (2027-2032) Table 119. Europe DNA Subcloning Services Revenue by Type (2021-2026) & (US$ Million) Table 120. Europe DNA Subcloning Services Revenue by Type (2027-2032) & (US$ Million) Table 121. Europe DNA Subcloning Services Revenue by Application (2021-2026) & (US$ Million) Table 122. Europe DNA Subcloning Services Revenue by Application (2027-2032) & (US$ Million) Table 123. Europe DNA Subcloning Services Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 124. Europe DNA Subcloning Services Revenue by Country (2021-2026) & (US$ Million) Table 125. Europe DNA Subcloning Services Revenue by Country (US$ Million) & (2027-2032) Table 126. China DNA Subcloning Services Revenue by Type (2021-2026) & (US$ Million) Table 127. China DNA Subcloning Services Revenue by Type (2027-2032) & (US$ Million) Table 128. China DNA Subcloning Services Revenue by Application (2021-2026) & (US$ Million) Table 129. China DNA Subcloning Services Revenue by Application (2027-2032) & (US$ Million) Table 130. Asia DNA Subcloning Services Revenue by Type (2021-2026) & (US$ Million) Table 131. Asia DNA Subcloning Services Revenue by Type (2027-2032) & (US$ Million) Table 132. Asia DNA Subcloning Services Revenue by Application (2021-2026) & (US$ Million) Table 133. Asia DNA Subcloning Services Revenue by Application (2027-2032) & (US$ Million) Table 134. Asia DNA Subcloning Services Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 135. Asia DNA Subcloning Services Revenue by Region (US$ Million) & (2021-2026) Table 136. Asia DNA Subcloning Services Revenue by Region (US$ Million) & (2027-2032) Table 137. SAMEA DNA Subcloning Services Revenue by Type (2021-2026) & (US$ Million) Table 138. SAMEA DNA Subcloning Services Revenue by Type (2027-2032) & (US$ Million) Table 139. SAMEA DNA Subcloning Services Revenue by Application (2021-2026) & (US$ Million) Table 140. SAMEA DNA Subcloning Services Revenue by Application (2027-2032) & (US$ Million) Table 141. SAMEA DNA Subcloning Services Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 142. SAMEA DNA Subcloning Services Revenue by Country (2021-2026) & (US$ Million) Table 143. SAMEA DNA Subcloning Services Revenue by Country (US$ Million) & (2027-2032) Table 144. Research Programs/Design for This Report Table 145. Authors List of This Report Table 146. Secondary Sources Table 147. Primary Sources List of Figures Figure 1. DNA Subcloning Services Image Figure 2. Global DNA Subcloning Services Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global DNA Subcloning Services Market Size Share 2021 VS 2025 VS 2032 Figure 4. Restriction Enzyme-based Subcloning Image Figure 5. PCR-based Subcloning Image Figure 6. Other Image Figure 7. Global DNA Subcloning Services Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global DNA Subcloning Services Market Size Share 2021 VS 2025 VS 2032 Figure 9. Biotechnology Image Figure 10. Pharmaceuticals Image Figure 11. Basic Research Image Figure 12. Others Image Figure 13. Global DNA Subcloning Services Market Size (US$ Million) & (2021-2032) Figure 14. Global DNA Subcloning Services Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global DNA Subcloning Services Market Share by Region: 2021 VS 2025 VS 2032 Figure 16. Global DNA Subcloning Services Players Revenue Share Top 10 and Top 5 in 2025 Figure 17. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global DNA Subcloning Services Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global DNA Subcloning Services Revenue Market Share 2021 VS 2025 VS 2032 Figure 20. Global DNA Subcloning Services Revenue Market Share by Type (2021-2032) Figure 21. Global DNA Subcloning Services Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global DNA Subcloning Services Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 23. Global DNA Subcloning Services Revenue Market Share by Application (2021-2032) Figure 24. North America DNA Subcloning Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 25. North America DNA Subcloning Services Revenue Share by Type (2021-2032) Figure 26. North America DNA Subcloning Services Revenue Share by Application (2021-2032) Figure 27. North America DNA Subcloning Services Revenue Share by Country (2021-2032) Figure 28. United States DNA Subcloning Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Canada DNA Subcloning Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Mexico DNA Subcloning Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Europe DNA Subcloning Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 32. Europe DNA Subcloning Services Revenue Share by Type (2021-2032) Figure 33. Europe DNA Subcloning Services Revenue Share by Application (2021-2032) Figure 34. Europe DNA Subcloning Services Revenue Share by Country (2021-2032) Figure 35. Germany DNA Subcloning Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. France DNA Subcloning Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. U.K. DNA Subcloning Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Italy DNA Subcloning Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Spain DNA Subcloning Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Russia DNA Subcloning Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Netherlands DNA Subcloning Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Nordic Countries DNA Subcloning Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. China DNA Subcloning Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. China DNA Subcloning Services Revenue Share by Type (2021-2032) Figure 45. China DNA Subcloning Services Revenue Share by Application (2021-2032) Figure 46. Asia DNA Subcloning Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 47. Asia DNA Subcloning Services Revenue Share by Type (2021-2032) Figure 48. Asia DNA Subcloning Services Revenue Share by Application (2021-2032) Figure 49. Asia DNA Subcloning Services Revenue Share by Region (2021-2032) Figure 50. Japan DNA Subcloning Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. South Korea DNA Subcloning Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. India DNA Subcloning Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Australia DNA Subcloning Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Taiwan DNA Subcloning Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Southeast Asia DNA Subcloning Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. SAMEA DNA Subcloning Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 57. SAMEA DNA Subcloning Services Revenue Share by Type (2021-2032) Figure 58. SAMEA DNA Subcloning Services Revenue Share by Application (2021-2032) Figure 59. SAMEA DNA Subcloning Services Revenue Share by Country (2021-2032) Figure 60. Brazil DNA Subcloning Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Argentina DNA Subcloning Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Chile DNA Subcloning Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Colombia DNA Subcloning Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Peru DNA Subcloning Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Saudi Arabia DNA Subcloning Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Israel DNA Subcloning Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. UAE DNA Subcloning Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Turkey DNA Subcloning Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Iran DNA Subcloning Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Egypt DNA Subcloning Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Restriction Enzyme-based Subcloning
  • PCR-based Subcloning
  • Other
Applications
  • Biotechnology
  • Pharmaceuticals
  • Basic Research
  • Others
Companies covered
  • Sydlabs
  • GenScript
  • Thermo Fisher Scientific
  • OriGene
  • Eton Bioscience
  • Synbio Technologies
  • Eurofins Genomics
  • Tsingke Biotech
  • MCLAB
  • Innoprot
  • Applied Biological Materials Inc. (abm)
  • BaseGene
  • Gencefebio
  • FIVEphoton Biochemicals
  • 1st BASE

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 DNA Subcloning Services Market by Type
  3. 1.2.1 Global DNA Subcloning Services Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Restriction Enzyme-based Subcloning
  5. 1.2.3 PCR-based Subcloning
  6. 1.2.4 Other
  7. 1.3 DNA Subcloning Services Market by Application
  8. 1.3.1 Global DNA Subcloning Services Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Biotechnology
  10. 1.3.3 Pharmaceuticals
  11. 1.3.4 Basic Research
  12. 1.3.5 Others
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 DNA Subcloning Services Market Dynamics
  1. 2.1 DNA Subcloning Services Industry Trends
  2. 2.2 DNA Subcloning Services Industry Drivers
  3. 2.3 DNA Subcloning Services Industry Opportunities and Challenges
  4. 2.4 DNA Subcloning Services Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global DNA Subcloning Services Market Perspective (2021-2032)
  2. 3.2 Global DNA Subcloning Services Growth Trends by Region
  3. 3.2.1 Global DNA Subcloning Services Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global DNA Subcloning Services Market Size by Region (2021-2026)
  5. 3.2.3 Global DNA Subcloning Services Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global DNA Subcloning Services Revenue by Players
  2. 4.1.1 Global DNA Subcloning Services Revenue by Players (2021-2026)
  3. 4.1.2 Global DNA Subcloning Services Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global DNA Subcloning Services Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global DNA Subcloning Services Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global DNA Subcloning Services Key Players Headquarters & Area Served
  7. 4.4 Global DNA Subcloning Services Players, Product Type & Application
  8. 4.5 Global DNA Subcloning Services Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global DNA Subcloning Services Market CR5 and HHI
  11. 4.6.3 2025 DNA Subcloning Services Tier 1, Tier 2, and Tier 3
5 DNA Subcloning Services Market Size by Type
  1. 5.1 Global DNA Subcloning Services Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global DNA Subcloning Services Revenue by Type (2021-2032)
  3. 5.3 Global DNA Subcloning Services Revenue Market Share by Type (2021-2032)
6 DNA Subcloning Services Market Size by Application
  1. 6.1 Global DNA Subcloning Services Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global DNA Subcloning Services Revenue by Application (2021-2032)
  3. 6.3 Global DNA Subcloning Services Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Sydlabs
  2. 7.1.1 Sydlabs Company Information
  3. 7.1.2 Sydlabs Business Overview
  4. 7.1.3 Sydlabs DNA Subcloning Services Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Sydlabs DNA Subcloning Services Product Portfolio
  6. 7.1.5 Sydlabs Recent Developments
  7. 7.2 GenScript
  8. 7.2.1 GenScript Company Information
  9. 7.2.2 GenScript Business Overview
  10. 7.2.3 GenScript DNA Subcloning Services Revenue and Gross Margin (2021-2026)
  11. 7.2.4 GenScript DNA Subcloning Services Product Portfolio
  12. 7.2.5 GenScript Recent Developments
  13. 7.3 Thermo Fisher Scientific
  14. 7.3.1 Thermo Fisher Scientific Company Information
  15. 7.3.2 Thermo Fisher Scientific Business Overview
  16. 7.3.3 Thermo Fisher Scientific DNA Subcloning Services Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Thermo Fisher Scientific DNA Subcloning Services Product Portfolio
  18. 7.3.5 Thermo Fisher Scientific Recent Developments
  19. 7.4 OriGene
  20. 7.4.1 OriGene Company Information
  21. 7.4.2 OriGene Business Overview
  22. 7.4.3 OriGene DNA Subcloning Services Revenue and Gross Margin (2021-2026)
  23. 7.4.4 OriGene DNA Subcloning Services Product Portfolio
  24. 7.4.5 OriGene Recent Developments
  25. 7.5 Eton Bioscience
  26. 7.5.1 Eton Bioscience Company Information
  27. 7.5.2 Eton Bioscience Business Overview
  28. 7.5.3 Eton Bioscience DNA Subcloning Services Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Eton Bioscience DNA Subcloning Services Product Portfolio
  30. 7.5.5 Eton Bioscience Recent Developments
  31. 7.6 Synbio Technologies
  32. 7.6.1 Synbio Technologies Company Information
  33. 7.6.2 Synbio Technologies Business Overview
  34. 7.6.3 Synbio Technologies DNA Subcloning Services Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Synbio Technologies DNA Subcloning Services Product Portfolio
  36. 7.6.5 Synbio Technologies Recent Developments
  37. 7.7 Eurofins Genomics
  38. 7.7.1 Eurofins Genomics Company Information
  39. 7.7.2 Eurofins Genomics Business Overview
  40. 7.7.3 Eurofins Genomics DNA Subcloning Services Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Eurofins Genomics DNA Subcloning Services Product Portfolio
  42. 7.7.5 Eurofins Genomics Recent Developments
  43. 7.8 Tsingke Biotech
  44. 7.8.1 Tsingke Biotech Company Information
  45. 7.8.2 Tsingke Biotech Business Overview
  46. 7.8.3 Tsingke Biotech DNA Subcloning Services Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Tsingke Biotech DNA Subcloning Services Product Portfolio
  48. 7.8.5 Tsingke Biotech Recent Developments
  49. 7.9 MCLAB
  50. 7.9.1 MCLAB Company Information
  51. 7.9.2 MCLAB Business Overview
  52. 7.9.3 MCLAB DNA Subcloning Services Revenue and Gross Margin (2021-2026)
  53. 7.9.4 MCLAB DNA Subcloning Services Product Portfolio
  54. 7.9.5 MCLAB Recent Developments
  55. 7.10 Innoprot
  56. 7.10.1 Innoprot Company Information
  57. 7.10.2 Innoprot Business Overview
  58. 7.10.3 Innoprot DNA Subcloning Services Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Innoprot DNA Subcloning Services Product Portfolio
  60. 7.10.5 Innoprot Recent Developments
  61. 7.11 Applied Biological Materials Inc. (abm)
  62. 7.11.1 Applied Biological Materials Inc. (abm) Company Information
  63. 7.11.2 Applied Biological Materials Inc. (abm) Business Overview
  64. 7.11.3 Applied Biological Materials Inc. (abm) DNA Subcloning Services Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Applied Biological Materials Inc. (abm) DNA Subcloning Services Product Portfolio
  66. 7.11.5 Applied Biological Materials Inc. (abm) Recent Developments
  67. 7.12 BaseGene
  68. 7.12.1 BaseGene Company Information
  69. 7.12.2 BaseGene Business Overview
  70. 7.12.3 BaseGene DNA Subcloning Services Revenue and Gross Margin (2021-2026)
  71. 7.12.4 BaseGene DNA Subcloning Services Product Portfolio
  72. 7.12.5 BaseGene Recent Developments
  73. 7.13 Gencefebio
  74. 7.13.1 Gencefebio Company Information
  75. 7.13.2 Gencefebio Business Overview
  76. 7.13.3 Gencefebio DNA Subcloning Services Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Gencefebio DNA Subcloning Services Product Portfolio
  78. 7.13.5 Gencefebio Recent Developments
  79. 7.14 FIVEphoton Biochemicals
  80. 7.14.1 FIVEphoton Biochemicals Company Information
  81. 7.14.2 FIVEphoton Biochemicals Business Overview
  82. 7.14.3 FIVEphoton Biochemicals DNA Subcloning Services Revenue and Gross Margin (2021-2026)
  83. 7.14.4 FIVEphoton Biochemicals DNA Subcloning Services Product Portfolio
  84. 7.14.5 FIVEphoton Biochemicals Recent Developments
  85. 7.15 1st BASE
  86. 7.15.1 1st BASE Company Information
  87. 7.15.2 1st BASE Business Overview
  88. 7.15.3 1st BASE DNA Subcloning Services Revenue and Gross Margin (2021-2026)
  89. 7.15.4 1st BASE DNA Subcloning Services Product Portfolio
  90. 7.15.5 1st BASE Recent Developments
8 North America
  1. 8.1 North America DNA Subcloning Services Revenue (2021-2032)
  2. 8.2 North America DNA Subcloning Services Revenue by Type (2021-2032)
  3. 8.2.1 North America DNA Subcloning Services Revenue by Type (2021-2026)
  4. 8.2.2 North America DNA Subcloning Services Revenue by Type (2027-2032)
  5. 8.3 North America DNA Subcloning Services Revenue Share by Type (2021-2032)
  6. 8.4 North America DNA Subcloning Services Revenue by Application (2021-2032)
  7. 8.4.1 North America DNA Subcloning Services Revenue by Application (2021-2026)
  8. 8.4.2 North America DNA Subcloning Services Revenue by Application (2027-2032)
  9. 8.5 North America DNA Subcloning Services Revenue Share by Application (2021-2032)
  10. 8.6 North America DNA Subcloning Services Revenue by Country
  11. 8.6.1 North America DNA Subcloning Services Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America DNA Subcloning Services Revenue by Country (2021-2026)
  13. 8.6.3 North America DNA Subcloning Services Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe DNA Subcloning Services Revenue (2021-2032)
  2. 9.2 Europe DNA Subcloning Services Revenue by Type (2021-2032)
  3. 9.2.1 Europe DNA Subcloning Services Revenue by Type (2021-2026)
  4. 9.2.2 Europe DNA Subcloning Services Revenue by Type (2027-2032)
  5. 9.3 Europe DNA Subcloning Services Revenue Share by Type (2021-2032)
  6. 9.4 Europe DNA Subcloning Services Revenue by Application (2021-2032)
  7. 9.4.1 Europe DNA Subcloning Services Revenue by Application (2021-2026)
  8. 9.4.2 Europe DNA Subcloning Services Revenue by Application (2027-2032)
  9. 9.5 Europe DNA Subcloning Services Revenue Share by Application (2021-2032)
  10. 9.6 Europe DNA Subcloning Services Revenue by Country
  11. 9.6.1 Europe DNA Subcloning Services Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe DNA Subcloning Services Revenue by Country (2021-2026)
  13. 9.6.3 Europe DNA Subcloning Services Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China DNA Subcloning Services Revenue (2021-2032)
  2. 10.2 China DNA Subcloning Services Revenue by Type (2021-2032)
  3. 10.2.1 China DNA Subcloning Services Revenue by Type (2021-2026)
  4. 10.2.2 China DNA Subcloning Services Revenue by Type (2027-2032)
  5. 10.3 China DNA Subcloning Services Revenue Share by Type (2021-2032)
  6. 10.4 China DNA Subcloning Services Revenue by Application (2021-2032)
  7. 10.4.1 China DNA Subcloning Services Revenue by Application (2021-2026)
  8. 10.4.2 China DNA Subcloning Services Revenue by Application (2027-2032)
  9. 10.5 China DNA Subcloning Services Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia DNA Subcloning Services Revenue (2021-2032)
  2. 11.2 Asia DNA Subcloning Services Revenue by Type (2021-2032)
  3. 11.2.1 Asia DNA Subcloning Services Revenue by Type (2021-2026)
  4. 11.2.2 Asia DNA Subcloning Services Revenue by Type (2027-2032)
  5. 11.3 Asia DNA Subcloning Services Revenue Share by Type (2021-2032)
  6. 11.4 Asia DNA Subcloning Services Revenue by Application (2021-2032)
  7. 11.4.1 Asia DNA Subcloning Services Revenue by Application (2021-2026)
  8. 11.4.2 Asia DNA Subcloning Services Revenue by Application (2027-2032)
  9. 11.5 Asia DNA Subcloning Services Revenue Share by Application (2021-2032)
  10. 11.6 Asia DNA Subcloning Services Revenue by Country
  11. 11.6.1 Asia DNA Subcloning Services Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia DNA Subcloning Services Revenue by Country (2021-2026)
  13. 11.6.3 Asia DNA Subcloning Services Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA DNA Subcloning Services Revenue (2021-2032)
  2. 12.2 SAMEA DNA Subcloning Services Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA DNA Subcloning Services Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA DNA Subcloning Services Revenue by Type (2027-2032)
  5. 12.3 SAMEA DNA Subcloning Services Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA DNA Subcloning Services Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA DNA Subcloning Services Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA DNA Subcloning Services Revenue by Application (2027-2032)
  9. 12.5 SAMEA DNA Subcloning Services Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA DNA Subcloning Services Revenue by Country
  11. 12.6.1 SAMEA DNA Subcloning Services Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA DNA Subcloning Services Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA DNA Subcloning Services Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst